Search

Your search keyword '"Mozhdehipanah, Hossein"' showing total 4 results
Start Over Author "Mozhdehipanah, Hossein" Journal multiple sclerosis and related disorders
4 results on '"Mozhdehipanah, Hossein"'

1. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics

Author

Ghadiri, Fereshteh, Sahraian, Mohammad Ali, Razazian, Nazanin, Ashtari, Fereshteh, Poursadeghfard, Maryam, Nabavi, Seyed Massood, Navardi, Samira, Baghbanian, Seyed Mohammad, Shaygannejad, Vahid, Harirchian, Mohammad Hossein, Beladimoghadam, Nahid, Majdinasab, Nastaran, Hosseini, Samaneh, Azimi, Amirreza, Kamali, Hoda, Sharifipour, Ehsan, Hosseini Nejad Mir, Nahid, Bayati, Asghar, Nahayati, Mohammad Ali, Heidari, Hora, Mozhdehipanah, Hossein, Ghalyanchi Langroodi, Hamidreza, Jalali, Nazanin, Ayoubi, Saeideh, Asadollahzadeh, Elnaz, Ebadi, Zahra, Eskandarieh, Sharareh, and Naser Moghadasi, Abdorreza

Published
2023
Full Text
View/download PDF

2. Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years

Author

Ghadiri, Fereshteh, primary, Sahraian, Mohammad Ali, additional, Baghbanian, Seyed Mohammad, additional, Ashtari, Fereshteh, additional, Razazian, Nazanin, additional, Majdinasab, Nastaran, additional, Poursadeghfard, Maryam, additional, Hatamian, Hamidreza, additional, Harirchian, Mohammad Hossein, additional, Beladimoghadam, Nahid, additional, Azimi, Amirreza, additional, Sharifipour, Ehsan, additional, Hosseini, Samaneh, additional, Bayati, Asghar, additional, Kamali, Hoda, additional, Hosseni Nejad Mir, Nahid, additional, Faraji, Fardin, additional, Mozhdehipanah, Hossein, additional, Modara, Farhad, additional, Navardi, Samira, additional, Heidari, Hora, additional, Ayoubi, Saeideh, additional, Naser Moghadasi, Abdorreza, additional, and Eskandarieh, Sharareh, additional

Published
2022
Full Text
View/download PDF

3. Characteristics of COVID-19 in patients with multiple sclerosis

Author

Ghadiri, Fereshteh, primary, Sahraian, Mohammad Ali, additional, Shaygannejad, Vahid, additional, Ashtari, Fereshteh, additional, Ghalyanchi Langroodi, Hamidreza, additional, Baghbanian, Seyed Mohammad, additional, Mozhdehipanah, Hossein, additional, Majdi-Nasab, Nastaran, additional, Hosseini, Samaneh, additional, Poursadeghfard, Maryam, additional, Beladimoghadam, Nahid, additional, Razazian, Nazanin, additional, Ayoubi, Saeideh, additional, Rezaeimanesh, Nasim, additional, Eskandarieh, Sharareh, additional, and Naser Moghadasi, Abdorreza, additional

Published
2022
Full Text
View/download PDF

4. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics

Author

Ghadiri, Fereshteh, Sahraian, Mohammad Ali, Razazian, Nazanin, Ashtari, Fereshteh, Poursadeghfard, Maryam, Nabavi, Seyed Massood, Navardi, Samira, Baghbanian, Seyed Mohammad, Shayegannejad, Vahid, Harirchian, Mohammad Hossein, Beladimoghadam, Nahid, Majdinasab, Nastaran, Hosseini, Samaneh, Azimi, Amirreza, Kamali, Hoda, Sharifipour, Ehsan, Mir, Nahid Hosseini Nejad, Bayati, Asghar, Nahayati, Mohammad Ali, Heidari, Hora, Mozhdehipanah, Hossein, Langroodi, Hamidreza Ghalyanchi, Jalali, Nazanin, Ayoubi, Saeideh, Zadeh, Elnaz Asadollah, Ebadi, Zahra, Eskandarieh, Sharareh, and Moghadasi, Abdorreza Naser

Abstract

•Around 1.6% of registered Iranian MS cases are in the late-onset (LOMS) category•The age-standardized LOMS prevalence was around 75 per 100000 people•About half of the Iranian LOMS cases suffered relapsing-remitting course•Nearly 23% of LOMS patients did not receive any disease-modifying treatment

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results